Larvol Delta - LOTUS-A-Study-of-Outcomes-in-Chinese-Patients-Treated-With-Anifrolumab-Who-Have-Active-Modsevere-Systemic-Lupus-Erythematosus

Saphnelo (anifrolumab-fnia) - AstraZeneca

http://clinicaltrials.gov/ct2/show/NCT07751848

Sep 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next